Evonik is currently not aiming for acquisitions.
“We will not make any acquisitions in the next two years,” said CEO Christian Kullmann of the Rheinische Post. “We are fully focused on the greatest conversion in Evonik history. Our triple jump – save, convert, grow – is complex enough. After 2027 we continue to see.”
By 2026, the chemical company wanted to decide on the future of service units: “By the end of the year we will exclude the service units at the Marl and Wesseling locations, where we have 3,600 employees,” said Kullmann. “For these units we check all options: keep, joint venture, sale to investors or to chemistry park operator. We will decide in 2026”
The announced Job cuts In the administration, meanwhile progress: “We will reduce 2,000 jobs in the administration by 2027, including 1,500 in Germany. Half is done.”
For the Evonik share, 2.0 percent in the post-market tradegate trade in the post-market tradegate trade.
Dow Jones
Selected leverage products on Evonik
With knock-outs, speculative investors can participate disproportionately in price movements. Simply choose the desired lever and we will show you suitable open-end products on Evonik
The lever must be between 2 and 20
Advertising